ByteDance completes $290 million fundraising for AI drug unit after its spin-off
ByteDance completes $290 million fundraising for AI drug discovery spin-off Anew Labs, valuing the Shanghai-based unit at $1.5 billion with backing from HSG, IDG, Hillhouse and others
Reuters1 min read
Share

Add Emirates 24|7 to your Google News
Text Size:
